Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, da Silva APM, de Barros ACSD, Carvalho A, de Lima VC, Carraro DM, Brentani HP, da Cunha IW, Soares FA, Parmigiani RB, Chammas R, Camargo AA, Costa ÉT. Jandrey EHF, et al. Among authors: costa et. NPJ Breast Cancer. 2019 Apr 5;5:11. doi: 10.1038/s41523-019-0106-x. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30963110 Free PMC article.
ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis.
Verbisck NV, Costa ET, Costa FF, Cavalher FP, Costa MD, Muras A, Paixão VA, Moura R, Granato MF, Ierardi DF, Machado T, Melo F, Ribeiro KB, Cunha IW, Lima VC, Maciel Mdo S, Carvalho AL, Soares FF, Zanata S, Sogayar MC, Chammas R, Camargo AA. Verbisck NV, et al. Among authors: costa md, costa ff, costa et. Cancer Res. 2009 Jul 1;69(13):5546-52. doi: 10.1158/0008-5472.CAN-08-2976. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549921
Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals.
Costa ET, Barnabé GF, Li M, Dias AA, Machado TR, Asprino PF, Cavalher FP, Ferreira EN, Del Mar Inda M, Nagai MH, Malnic B, Duarte ML, Leite KR, de Barros AC, Carraro DM, Chammas R, Armelin HA, Cavenee W, Furnari F, Camargo AA. Costa ET, et al. Oncogene. 2015 Mar 5;34(10):1270-9. doi: 10.1038/onc.2014.70. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662834
Fibronectin affects transient MMP2 gene expression through DNA demethylation changes in non-invasive breast cancer cell lines.
Pereira IT, Ramos EA, Costa ET, Camargo AA, Manica GC, Klassen LM, Chequin A, Braun-Prado K, Pedrosa Fde O, Souza EM, Costa FF, Klassen G. Pereira IT, et al. Among authors: costa ff, costa et. PLoS One. 2014 Sep 10;9(9):e105806. doi: 10.1371/journal.pone.0105806. eCollection 2014. PLoS One. 2014. PMID: 25208219 Free PMC article.
High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.
Campesato LF, Silva APM, Cordeiro L, Correa BR, Navarro FCP, Zanin RF, Marçola M, Inoue LT, Duarte ML, Molgora M, Pasqualini F, Massara M, Galante P, Barroso-Sousa R, Polentarutti N, Riva F, Costa ET, Mantovani A, Garlanda C, Camargo AA. Campesato LF, et al. Among authors: costa et. Oncotarget. 2017 Jul 25;8(30):49470-49483. doi: 10.18632/oncotarget.17713. Oncotarget. 2017. PMID: 28533483 Free PMC article.
85 results